Generation and purification of ACTH-secreting hPSC-derived pituitary cells for effective transplantation

Stem Cell Reports. 2023 Aug 8;18(8):1657-1671. doi: 10.1016/j.stemcr.2023.05.002. Epub 2023 Jun 8.

Abstract

Pituitary organoids are promising graft sources for transplantation in treatment of hypopituitarism. Building on development of self-organizing culture to generate pituitary-hypothalamic organoids (PHOs) using human pluripotent stem cells (hPSCs), we established techniques to generate PHOs using feeder-free hPSCs and to purify pituitary cells. The PHOs were uniformly and reliably generated through preconditioning of undifferentiated hPSCs and modulation of Wnt and TGF-β signaling after differentiation. Cell sorting using EpCAM, a pituitary cell-surface marker, successfully purified pituitary cells, reducing off-target cell numbers. EpCAM-expressing purified pituitary cells reaggregated to form three-dimensional pituitary spheres (3D-pituitaries). These exhibited high adrenocorticotropic hormone (ACTH) secretory capacity and responded to both positive and negative regulators. When transplanted into hypopituitary mice, the 3D-pituitaries engrafted, improved ACTH levels, and responded to in vivo stimuli. This method of generating purified pituitary tissue opens new avenues of research for pituitary regenerative medicine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenocorticotropic Hormone*
  • Animals
  • Cell Culture Techniques / methods
  • Cell Differentiation
  • Epithelial Cell Adhesion Molecule
  • Humans
  • Mice
  • Pluripotent Stem Cells*

Substances

  • Adrenocorticotropic Hormone
  • Epithelial Cell Adhesion Molecule